3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
35
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
19
Lymphoma, Non-Hodgkin
11
Hodgkin Disease
10
Leukemia, Biphenotypic, Acute
8
Multiple Myeloma
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia
7
Burkitt Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Neuroblastoma
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large B-Cell, Diffuse
5
Anemia, Refractory, with Excess of Blasts
5
Recurrence
4
Lymphoma
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Hematologic Neoplasms
4
Breast Neoplasms
4
Lymphoma, T-Cell
3
Lymphoma, Follicular
3
Leukemia, Myelomonocytic, Chronic
3
Sarcoma
2
Rhabdomyosarcoma
2
Primary Myelofibrosis
2
Neoplasms, Plasma Cell
2
Myelodysplastic-Myeloproliferative Diseases
2
Medulloblastoma
2
Interventions
Carboplatin
47
Etoposide
46
durvalumab
28
atezolizumab
28
Cisplatin
21
Topotecan
19
pembrolizumab
15
PM 01183
15
Nivolumab
12
Specimen Handling
11
anlotinib
9
Radiotherapy
9
Paclitaxel
9
Drug Therapy
9
Temozolomide
8
Magnetic Resonance Spectroscopy
8
AMG 757
8
Radiosurgery
7
Platinum
7
Irinotecan
7
toripalimab
6
olaparib
6
Biopsy
6
Ipilimumab
5
Injections
5
Docetaxel
5
Bevacizumab
5
trilaciclib
4
tremelimumab
4
tislelizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Granulocyte Colony-Stimulating Factor
×
1 year
×
Clear all
No trials found.